• 113027+ Medical Conferences
  • 237 Specialties
  • 23086 Organizers
  • 136271 Speakers
  • 153 Countries
  • 4127 Cities
CME Conference Registrations Sold
Home  >  Speakers  >  Praveen Advani
Praveen Advani

Praveen Advani

Executive Director | Raritan, New Jersey    United States of America
Oncology, Pharmacy And Medicine,...More
Pharmaceuticals, Market Research,...More
Spoken at 4 events

Biography :

Praveen Advani, Executive Director, WW Immuno-Oncology Market Research, Bristol-Myers Squibb Praveen Advani has more than 17 years of experience leading global market research efforts for new products and in-line brands in the Pharmaceutical Industry. Praveen is currently Executive Director, Worldwide Market Research – Immuno-Oncology at Bristol-Myers Squibb.

He was previously the Director & Team Leader for Womens Health, Insomnia and Pain Franchises in Global Market Research & Analytics at Merck. In his 9 years at Merck, he successfully led global market research efforts for the launches of Diabetes (Januvia/Janumet) and Glaucoma (Saflutan) drugs. Prior to Merck, Praveen was with Aventis Pharmaceuticals (now Sanofi-Aventis) for over 6 years and was instrumental in leading global market research for the successful launch of Lantus.

Praveen holds a M.B.A. from Thunderbird, The American Graduate School of International Management and a Bachelors degree in Engineering from the University of Pune, India

For speaker's contact information - Contact us


Oncology, Pharmacy and Medicine, Immunology and Microbiology

Interested Topics

Pharmaceuticals, Market Research, Immuno Oncology, Diabetes, Insomnia, Global Marketing, Global Strategy, Market Analysis, Pharmaceutical Industry, Competitive Analysis, Competitive Intelligence, Neuroscience, Parkinsons, Insomnia

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.



Conference Session Materials

The conference session material has yet to be added by the speaker.

Send Message